Duma Narjust, Sanchez Larysa J, Castro Yulanka S, Jennis Andrew A, McCain Donald A, Gutierrez Martin E, Bamboat Zubin M
Department of Internal Medicine, Newark, Rutgers-New Jersey Medical School (Narjust Duma, Larysa J. Sanchez, Yulanka S. Castro), NJ, USA.
Department of Medical and Surgical Oncology, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack (Andrew A. Jennis, Donald A. McCain, Martin E. Gutierrez, Zubin M. Bamboat), NJ, USA.
Ann Gastroenterol. 2016 Jul-Sep;29(3):325-31. doi: 10.20524/aog.2016.0030. Epub 2016 Apr 7.
Gastriccancer is a leading cause of cancer death worldwide and has significant ethnic and socioeconomic differences in distribution. The aim of this study was to compare clinicopathologic characteristics and survival between Hispanics (H) and non-Hispanic whites (NHW) with gastric cancer.
We reviewed the records of all patients diagnosed with gastric cancer between 1999 and 2013 at our institution. A total of 638 patients were studied. Demographics, tumor characteristics and survival rate were analyzed. Kaplan-Meier was used for survival analysis.
There were 101 H and 537 NHW. The median age at diagnosis was 63 years in H and 69 years in NHW. At diagnosis, 48 (48%) of H patients had stage IV disease compared with 195 (36%) of NHW (P<0.03). H were more likely to have distal cancers and poorly differentiated tumors compared to NHW (44% vs. 15%, P<0.0001; 70% vs. 50%, P<0.0002, respectively). There was a significant difference in median overall survival between the two groups, being 51 months for H (95% CI: 34.6-66.9) and 99 months for NHW (95% CI: 77.3-120.7) P<0.0001. In multivariate analysis, age (OR: 1.02, 95% CI: 1.02-1.03, P<0.0001), poor differentiation (OR: 1.21, 95% CI: 1.02-1.43, P<0.02), ethnicity (OR: 1.69, 95% CI: 1.07-2.55, P<0.02), and stage (OR: 1.95, 95% CI: 1.77-2.15, P<0.0001) were independent predictors of survival.
H patients were diagnosed with gastric cancer at a younger age, to present with advanced disease at diagnosis, and had shorter overall survival compared to NHW.
胃癌是全球癌症死亡的主要原因,在分布上存在显著的种族和社会经济差异。本研究的目的是比较西班牙裔(H)和非西班牙裔白人(NHW)胃癌患者的临床病理特征和生存率。
我们回顾了1999年至2013年在我们机构诊断为胃癌的所有患者的记录。共研究了638例患者。分析了人口统计学、肿瘤特征和生存率。采用Kaplan-Meier法进行生存分析。
有101例西班牙裔患者和537例非西班牙裔白人患者。西班牙裔患者诊断时的中位年龄为63岁,非西班牙裔白人患者为69岁。诊断时,48%(48例)的西班牙裔患者为IV期疾病,而非西班牙裔白人患者为36%(195例)(P<0.03)。与非西班牙裔白人相比,西班牙裔患者更易患远端癌症和低分化肿瘤(分别为44%对15%,P<0.0001;70%对50%,P<0.0002)。两组患者的中位总生存期存在显著差异,西班牙裔患者为51个月(95%CI:34.6 - 66.9),非西班牙裔白人患者为99个月(95%CI:77.3 - 120.7),P<0.0001。在多变量分析中,年龄(OR:1.02,95%CI:1.02 - 1.03,P<0.0001)、低分化(OR:1.21,95%CI:1.02 - 1.43,P<0.02)、种族(OR:1.69,95%CI:1.07 - 2.55,P<0.02)和分期(OR:1.95,95%CI:1.77 - 2.15)P<0.0001)是生存的独立预测因素。
与非西班牙裔白人相比,西班牙裔胃癌患者诊断时年龄较轻,诊断时多为晚期疾病,总生存期较短。